Our Washington Township location is now open

Click Here For More Information

Brolucizumab Receives FDA Approval for Wet AMD

Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.